Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
PORK POULTRY
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Pig Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Pig Health Today | Sponsored by Zoetis

.

Five steps to better Mycoplasma hyopneumoniae control

By Lucina Galina, DVM, PhD
Director, Pork Technical Services, Zoetis

 

For pig producers and veterinarians, the health and economic impact of Mycoplasma hyopneumoniae (M. hyo.) is clear. In the US, enzootic pneumonia caused by M. hyo. is considered one of the “big three” respiratory diseases in swine, following porcine respiratory and reproductive syndrome (PRRS) and influenza.

Economic losses due to reduced growth, poor feed efficiency and extended time to market can significantly hurt the producer’s bottom line. Recent estimates indicate that the cost of uncomplicated M. Hyo infections in large production systems is more than $1.00 per pig and $10 in M. hyo.-positive sites co-infected with influenza and PRRS virus.1

Often less clear, however, is how to manage this costly and persistent pathogen. Overall, disease control has improved in recent years, thanks to the production of M. Hyo– and PRRSv-negative breeding stock, the adoption of segregated systems — in which pigs of a similar age are raised and moved together — and the development of strategic treatment and vaccination protocols.

The challenge is that differences in the M. hyo. health status of incoming breeding stock and sows at the recipient farm can have a negative impact on health — with costly consequences.

M. hyo.-control challenges

For example, when M. hyo.-negative gilts are introduced in M. hyo.-positive systems without proper acclimation, subclinical or clinical disease can develop, increasing vertical transmission from dam to piglet. Higher rates of vertical transmission mean more pigs colonized at weaning, which is the greatest predictor of clinical disease in the finishing herd.2

We have also learned that pigs that have been exposed to M. hyo. can continue shedding for up to 250 days.3 Controlling shedding in a population is the most challenging aspect of disease control since there are currently no reliable methods of ensuring uniform exposure of all animals in a population. Additionally, facilities that allow for a long enough “cool-down” period to discontinue shedding are rarely available.

Vaccination, medication and proper all-in, all-out movement of pigs are therefore necessary but insufficient for preventing colonization. Successful M. Hyo control must begin with acclimating gilts, as part of a comprehensive plan that includes multiple strategies.

Five steps

To help veterinarians and producers get a better handle on M. hyo. control, my Zoetis colleagues and I teamed up with eight experts from animal health, academia, diagnostics, swine veterinary practice and a breeding-stock company to review the latest knowledge and best practices for managing M. hyo.

The outcome is a 60-page manual, titled “A Contemporary Review of Mycoplasma hyopneumoniae Control Strategies,” which outlines a systematic, five-step approach for managing M. hyo. in today’s segregated production systems:

1. Establish current herd status of M. hyo. on the farm and set appropriate goals.

A breeding-herd classification allows veterinarians to determine a baseline and set appropriate goals. For example, a positive, unstable herd is likely to require a more aggressive control strategy than a positive, stable herd. The use of a common classification language should also improve communication between stakeholders, including veterinarians, producers, diagnosticians and breeding-stock companies. A summary of the four M. hyo. categories for breeding herds is shown in Figure 1.

Figure 1

Most swine herds fall within one of the herd categories outlined in the table above, but their responses to challenges may not always be black and white. The most critical guideline is the percentage of pigs colonized at weaning. This criterion clearly differentiates positive, unstable herds from positive, stable ones.

2. Leverage diagnostic techniques that reveal your current status.

The appropriate diagnostic approach for your farm will depend on which question needs to be answered. The question could be whether M. hyo. is present in the population, or whether M. hyo. is causing disease. These are two different questions that call for different diagnostic approaches.

Detailed diagnostic requirements for health-status categories, shown in Figure 2, take into account the expected prevalence of M. hyo. in the population, as well as the sensitivity of the sampling technique and diagnostic tests. Testing should be repeated, regardless of which diagnostic method is used.4

Figure 2

 

3. Understand and manage risk factors that influence disease transmission at all stages of production.

Many factors influence M. hyo. transmission. Some important risk factors include location of infected facilities within a 9 km (5.6 mi) radius, lack of isolation and acclimation facilities, lack of gilt exposure programs, introduction of replacement breeding stock with different health status, insufficient time for gilts to discontinue shedding, high proportion of at-risk females, poor lactation management, poor pig management and lack of vaccination.

Adequate biosecurity is critical to mitigate or eliminate these risk factors. Some biosecurity risks include transmission via fomites, equipment and transport; lack of cleaning, disinfection and drying of facilities; lack of all-in, all-out movement in the farrowing room; and the presence of concurrent diseases.

Understanding risk factors helps determine the most realistic and sustainable control strategy. For example, trying to achieve a negative status using disease elimination may not be suitable in an unstable herd that has a high risk of re-infection due to its location. Disease control could be achieved by moving to a healthier status such as stable herd.

4. Consider control measures, including maintaining a negative herd, vaccination, medication and disease elimination.

If your herd is negative, the best strategy is to keep it that way. If your herd is positive, control can be achieved by minimizing disease with vaccination or medication or by eliminating M. hyo. Vaccination and medication alone — without being part of a disease-elimination strategy — can be expected to reduce clinical signs, shedding and economic losses but not to eliminate the organism from the population. Vaccination of weaned pigs is unlikely to result in full disease control in finishers if the sow farm is unstable.

Medication can be used for control, treatment or disease elimination. For successful disease elimination, gilts should be acclimated to stabilize the sow herd. Then, the breeding herd will go through exposure and recovery phases, during which all pigs must be exposed to M. hyo. and be confirmed positive before strategic medication, disinfection and vaccination.

All these steps should be carried out with proper timing and orchestration. The goal is to eliminate M. hyo. shedding from mother to piglet and reduce the number of positive piglets at weaning.

5. Monitor the efficacy of interventions.

Control interventions should be monitored every 6 to12 months to determine if the herd status has been maintained (Figure 3). There are multiple sampling procedures and diagnostic tests for monitoring M. hyo. infection, colonization and disease progress.

Choice of procedure depends on several factors, including infection, clinical signs, disease prevalence, pig age, sampling technique, diagnostic test sensitivity and time to develop antibody response. Most important is to be certain of the current status of the population; the herd must meet the diagnostic criteria shown in Figure 2 to properly determine the correct classification.

Figure 3

For a free download of “A Contemporary Review of Mycoplasma hyopneumoniae Control Strategies,” click here.

 

 

 

 

Editor’s note: The opinions and recommendations presented in this article are the author’s and are not necessarily shared by the editors of Pig Health Today or its sponsor.

 

 

 

 

1. Haden et al. Am Assoc Swine Veterinarians proceedings, 2012
2. Fano et al. Can J Vet Res, 2005
3. Pieters et al. Vet Microbiol, 2009
4. Galina, L. Am Assoc Swine Veterinarians proceedings 2016.

 

 

 

 

 

 


tags: , , ,
RELATED NEWS
  • PCV2: Future considerations for an evolving virus

    Porcine circovirus type 2 (PCV2) may not be a new virus challenge for pork producers and swine veterinarians, but it remains a constant challenge.

  • The last word: Our focus is pig health

    Welcome to Pig Health Today, a new magazine we’re sponsoring to keep US producers, veterinarians, nutritionists and other decision makers on top of the latest developments in disease management and pig care.

  • Air-cleaning technology could slash respiratory disease risk

    A technology that reduces dust, germs and gasses from the air in pig sheds could help cut the number of pigs that develop lesions associated with respiratory disease.

  • Accurate Mycoplasma hyopneumoniae diagnosis challenging but essential

    The diagnosis of Mycoplasma hyopneumoniae (M. hyo) infection remains challenging but can be made with confidence when a systematic approach is applied and the clinical picture aligns with laboratory tests.




You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.